Haim Belinson
Chief Executive Officer CaVos Biotherapeutics
Seminars
Wednesday 22nd July 2026
Evolution-Inspired Next-Gen mRNA Therapeutics for Longevity
1:30 pm
- Evolutionary AI Platform: Discovery of first-in-class therapeutic mRNA leads converged in long-lived species
- In Vitro Success: Hit-to-multicistronic mRNA translation, showcasing crosstalk in fibrosis modulation
- Next Steps: Advancing mRNA and LNP therapeutics toward IND
